Page 11 - Coronavirus Vaccine

China's daily Covid-19 cases hit record high at 32,695; curbs tightened

China on Friday reported another record high of daily Covid-19 infections, as cities across the country enforce measures and curbs to control outbreaks

Vaccinated people now make majority of Covid deaths in US: Report

"In September 2021, vaccinated people made up just 23 per cent of coronavirus fatalities. In January and February this year, it was up to 42 per cent," the report mentioned

SK Bioscience suspends production of Covid-19 vaccine 'Sky Covione'

It previously obtained item approval on June 29 and supplied vaccines on September under a pre-purchase contract with the government, but suspended production due to low market demand

Data story: India adds 408 new Covid cases; active tally at 5,881

India has added 3,807 cases in the past 7 days

Data story: India adds 360 new Covid cases; death toll at 530,596

India has added 3,399 cases in the past 7 days.

Removing vaccination mandate for incoming tourists correct move: Experts

With over 90% of population being vaccinated, it is okay at a policy level to relax the mandatory vaccination norm for entering India, they say

Data story: India records 294 new Covid cases; active tally at 6,209

India has so far administered 2,198,712,952 vaccine doses

Risk of myocarditis after Covid vaccination increases but very low: Study

According to a study, myocarditis after SARS-CoV-2 vaccination was rare but higher in younger males, particularly after the second mRNA-1273 (Moderna) vaccine

Govt scraps filling Air Suvidha form for international travellers

The requirement of random post-arrival testing of 2 per cent of arriving passengers too has been done away with in the new guideline

Covid-19 infection may reactivate several latent viruses in body: Study

COVID-19 can reactivate several latent viruses lurking in the body's cells following previous infections, particularly in people with chronic fatigue syndrome, according to a study. The findings, published in the journal Frontiers in Immunology, contribute to our understanding of the causes of myalgic encephalomyelitis/chronic fatigue syndrome, also known as ME/CFS, and prospects of reaching a diagnosis. Severe, long-term fatigue, post-exertional malaise, pain and sleep problems are characteristic signs of the disease. The causes of the condition are not known with certainty, although it has been established that the onset in most cases follows a viral or bacterial infection. "Our study now shows that objective measurements are available that show physiological differences in the body's reaction to viruses between ME patients and healthy controls," said Anders Rosen, a professor at Linkoping University, Sweden, and leader of the study. The extensive spread of the SARS-CoV-2 ...

Do you still need to wear a mask? Here's what doctors have to say

Doctors say that most people have some form of immunity against the virus already

Health Ministry rejects claim Covaxin was rushed due to political pressure

The media reports had claimed that Bharat Biotech, manufacturer of the indigenous Covaxin, 'had to skip certain processes' and 'speed' up clinical trials due to political pressure.

A viral message in the Moderna story

In The Messenger, The Wall Street Journal reporter Peter Loftus charts the journey of Moderna from being a languishing biotech start-up to one of the biggest financial beneficiaries of the pandemic

Covid curbs increased in China factory hub Guangzhou as outbreak balloons

In-person classes in eight of the city of some 19 million people's 11 districts will be halted from Thursday, officials said late Wednesday

WHO reports nearly 90% drop in Covid deaths globally since February

The World Health Organisation chief on Wednesday said a nearly 90% drop in recent COVID-19 deaths globally compared to nine months ago provides cause for optimism, but still urged vigilance against the pandemic as variants continue to crop up. Director-General Tedros Adhanom Ghebreyesus said that last week just over 9,400 deaths linked to the coronavirus were reported to the WHO. In February of this year, he said, weekly deaths had topped 75,000 globally. We have come a long way, and this is definitely cause for optimism. But we continue to call on all governments, communities and individuals to remain vigilant, he said at a virtual news conference from the WHO's Geneva headquarters. Almost 10,000 deaths a week is 10,000 too many for a disease that can be prevented and treated. The WHO chief said testing and sequencing rates remain low globally, vaccination gaps between rich and poor countries are still wide, and new variants continue to proliferate. The U.N. health agency said th

Covid will be there forever but worst is over: White House official

COVID-19 in some ways will be there forever but the worst days of the pandemic are "absolutely" over, Dr Ashish K Jha, the White House Coronavirus Response Coordinator, said on Tuesday. Speaking at the 20th Hindustan Times Leadership Summit, Jha said given the high levels of immunity in the population due to both vaccination and prior infections, "even if we see surges and variants the worst of this pandemic should be behind us". "Covid is not over and in some ways it will be with us forever and we just have to continue to manage it but if the question is are the worst days of covid behind us then my answer is absolutely, it is," he said. With variants cropping up at regular intervals, Jha acknowledged that they are a concern as a very rapid evolution of this virus is being seen over the time. "...the speed at which SARS-CoV-2 is evolving is really remarkable. And there are a variety of reasons why this is happening - the primary one is we have so much immunity across the world due

Japan govt urged to end free Covid-19 vaccinations amid financial strains

An advisory panel for the finance minister has proposed that the Japanese government end free-of-charge coronavirus vaccinations, highlighting concerns over a further increase of its financial strain

50 mn doses of Covaxin set to expire early 2023 due to poor off take

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said. Due to lack of product demand, Production stoppage of Covaxin- a two dose jab, was initiated by Bharat Biotech earlier this year, though the vaccine maker has established manufacturing to reach an annualised capacity of 1 billion doses at the end of 2021. Bharat Biotech has more than 200 million doses of Covaxin in bulk form and approximately 50 million doses in vials ready to use. Due to lack of product demand, production stoppage of Covaxin was initiated several months ago, earlier this year, sources told PTI. Covaxin doses in vials are set to expire during early 2023, resulting in losses for the company, sources further said. However, the quantum of loss that the Bharat Biotech would incur in the event of all the 50 million doses expiring next year is not known. India reported 1,082 fresh .

Biotech firm Bharat Serums & Vaccines working to reduce import dependence

Firm is develop recombinant products in hormones, eyes acquisitions in South East Asia

Data story: India adds 1,604 new Covid cases; active tally at 18,317

India has added 9,524 cases in the past 7 days